Withaferin A targets apoptosis inhibitor cIAP1: A potential anticancer candidate

Journal of Applied Pharmaceutical Science

Volumn 2, Issue 5, 2012, Pages 154-157

  Wadegaonkar, V P ^a   Wadegaonkar, P A ^a  

^a SANT GADGE BABA AMRAVATI UNIVERSITY   (India)

Author keywords

Apoptosis; Inhibitors of apoptosis; Withania somnifera

Indexed keywords

EID: 84876017222     PISSN: None     EISSN: 22313354     Source Type: Journal    
DOI: 10.7324/JAPS.2012.2527     Document Type: Article

References (17)

1. Anjaneyulu A.S.R., Rao D.S., Lequesne P.W. Withanolides, biologically active natural steroidal lactones: A review. Studies in Natural Products Chemistry. 1997; 20 (F): 135-261
2. Berman H.M., Westbrook J., Feng Z., Gilliland G., Bhat T.N. The protein data bank. Nucleic Acids Research. 2000; 28: 235-242
3. Boehm H. The computer program LUDI: A new method for the de novo design of enzyme inhibitors. Journal of Computer-Aided Molecular Design. 1992; 6, 61-78
4. Christina R. Arnt, Chiorean M.V., Heldebrant M.P., Gores G.J., Kaufmann S.H. Synthetic Smac/DIABLO Peptides Enhance the Effects of Chemotherapeutic Agents by Binding XIAP and cIAP1 in Situ. Journal of Biological Chemistry. 2002; 277: 44236-44243.
5. Cossu F., Malvezzi F., Canevari G., Mastrangelo E., Lecis D., Delia D., Seneci P., Scolastico C., Bolognesi M., Milani M. Recognition of Smac-mimetic compounds by the BIR domain of cIAP1. Protein science. 2010; 19 (12): 2418-2429
6. Dubrez-Doloz L., Dupoux A., Cartier J. (2008) IAPs: More than just inhibitors of apoptosis proteins. Cell Cycle 7(8): 1036-1046
7. Evan G.I., Vousden K.H. Proliferation, cell cycle and apoptosis in cancer. Nature. 2001; 411 (6835): 342-348
8. Grover A, Shandilya A., Bisaria V. and Sundar D. Probing the anticancer mechanism of prospective herbal drug Withaferin A on mammals: a case study on human and bovine proteasomes. BMC Genomics 2010, 11(Suppl 4): S4-S15
9. Grover A., Shandilya A., Agrawal V., Bisaria V., Pratik P., Bhasme D. and Sundar D. Hsp90/Cdc37 Chaperone/co-chaperone complex, a novel junction anticancer target elucidated by the mode of action of herbal drug Withaferin A. BMC Bioinformatics 2011, 12(Suppl 1): S1-S30
10. Gyrd-Hansen M., Meier P. IAPs: from caspase inhibitors to modulators of NF-?B, inflammation and cancer. Nature Reviews Cancer. 2010; 10, 561-574
11. Hanahan D., Weinberg R.A. The hallmarks of cancer. Cell. 2000; 100(1): 57-70
12. Hunter A.M., LaCasse E.C., Korneluk R.G. The inhibitors of apoptosis (IAPs) as cancer targets. Apoptosis. 20007; 12: 1543-1568
13. Imoto I., Yang Z.Q., Pimkhaokham A., Tsuda H., Shimada Y., Imamura M., Ohki M., Inazawa J. Identification of cIAP1 as a candidate target gene within an amplicon at 11q22 in esophageal squamous cell carcinomas. Cancer Research. 2001; 61: 6629-6634
14. Jayaprakasam B., Zhang Y, Seeram N.P., Nair M.G. Growth inhibition of human tumor cell lines by withanolides from Withania somnifera leaves. Life Sciences. 2003; 74(1): 125-132
15. Samuel T., Welsh K., Lober T., Togo S.H., Zapata J.M., Reed J.C. Distinct BIR Domains of cIAP1 Mediate Binding to and Ubiquitination of Tumor Necrosis Factor Receptor-associated Factor 2 and Second Mitochondrial Activator of Caspases. The Journal of Biological Chemistry. 2006; 281: 1080-1090
16. Wadegaonkar P.A., Bhagwat K.A., Rai M. Direct rhizogenesis and establishment of fast growing normal root organ culture of Withania somnifera Dunal. Plant Cell, Tissue and Organ Culture. 2006; 84, 100202-100204
17. Wu G., Chai J., Suber T.L., Wu J.W., Du C., Wang X., Shi Y. Structural basis of IAP recognition by Smac/DIABLO. Nature. 2000; 408 (6815): 1008-1012.